Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV001261918 | SCV001439248 | uncertain significance | Gray platelet syndrome | 2020-03-01 | criteria provided, single submitter | research | ACMG criteria: PM2, PP3, PP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699244 | SCV005205391 | uncertain significance | not specified | 2024-06-03 | criteria provided, single submitter | clinical testing | Variant summary: NBEAL2 c.7501C>T (p.His2501Tyr) results in a conservative amino acid change located in the Neurobeachin, beta-propeller domain (IPR046851) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 1608878 control chromosomes (gnomAD v4.1). c.7501C>T has been reported in the literature in an individual affected with Gray Platelet Syndrome (Sims_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 32693407). ClinVar contains an entry for this variant (Variation ID: 982291). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |